Legislation


S 320 – New York

Status: In Process
Year Introduced: 2021
Link: https://www.nysenate.gov/legislation/bills/2021/S320

Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing. The added section empowers the superintendent to investigate any increase in a “critical prescription drug” as defined in the amendment that exceeds
the consumer list price index during any preceding twelve month period.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found